Kursprognose für Supernus Pharmaceuticals Inc (SUPN)SUPNSupernus Pharmaceuticals Inc

Alphio's SUPN stock price prediction model matches the current Supernus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.96 (-0.27%). The 1-week path is $42.39 (+0.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Supernus Pharmaceuticals Inc is currently not a strong buy due to significant recent losses and negative technical indicators. The current price is $37.88, and the stock has a 5-day change of -11.23%. Additionally, the RSI is extremely low at 13.38, indicating oversold conditions, but this also suggests potential for a rebound. However, the company reported a net loss exceeding $58 million in Q2 2026, contrasting sharply with a net income of $22.5 million in Q2 2025, highlighting ongoing financial struggles. The main risk is the insider selling, which increased by 2510.70% over the last month, signaling a lack of confidence among insiders. Therefore, while the stock may have potential long-term upside due to the merger with Indivior, the current financial and technical indicators suggest a hold position for now.

Supernus Pharmaceuticals Inc (SUPN) last closed at $42.07, gaining +2.09%. These facts feed the 1-day and 1-week SUPN price prediction above.